Literature DB >> 21441076

How safe is the intravasation limit in hysteroscopic surgery?

B M P Rademaker1, P J M van Kesteren, P de Haan, D Rademaker, C France.   

Abstract

BACKGROUND: Transcervical resection of myomas (TCR-M) is considered a safe hysteroscopic procedure if intravasation is limited. Complications may occur if gas formation during myoma resection leads to gaseous embolism. However, the incidence of emboli during transcervical myoma resection is unknown. Therefore in this study the occurrence of physiological changes that indicate the formation of emboli was retrospectively determined in patients undergoing hysteroscopic myoma resection. In addition, these changes were related to the amount of fluid intravasation.
METHODS: The anesthesia records and operation files of 234 patients were screened for physiological changes that indicate embolism, as measured with standard intraoperative monitoring. These patients underwent surgery for intrauterine myomas with either a monopolar resectoscope with electrolyte-free distension fluid containing 3% sorbitol (limited to 1500-mL intravasation) or a bipolar resectoscope with normal saline solution (limited to 2500-mL intravasation). The patients were grouped according to the amount of fluid intravasation during the operation: Group 1: 500 mL or less, group 2: 500-1000 mL, group 3: 1000-1500 mL, and group 4: 1500-2500 mL.
RESULTS: Physiological changes that could be attributed to gaseous embolism were observed in 33% to 43% of patients with 1000 to 2500 mL fluid intravasation during transcervical myoma resection. Nearly half of those patients had cardiovascular disturbances that indicated the formation of emboli.
CONCLUSION: During transcervical resection of myomas, physiological changes that could be attributed to gaseous embolism frequently occurred. Therefore cardiovascular disturbances that indicate gaseous embolism during transcervical resection of myomas may occur despite the limitation of intravasation according to current view.
Copyright © 2011 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21441076     DOI: 10.1016/j.jmig.2011.01.010

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  2 in total

1.  The HYSTER study: the effect of intracervically administered terlipressin versus placebo on the number of gaseous emboli and fluid intravasation during hysteroscopic surgery: study protocol for a randomized controlled clinical trial.

Authors:  Lucilla E Overdijk; Bart M P Rademaker; Paul J M van Kesteren; Peter de Haan; Robert K Riezebos; Oscar C H Haude
Journal:  Trials       Date:  2018-02-14       Impact factor: 2.279

2.  Intraoperative venous air embolism in the non-cardiac surgery-the role of perioperative echocardiography in a case series report.

Authors:  Jingjing Ji; Yali Tian; Luning Chen; Bingbing Li
Journal:  Ann Transl Med       Date:  2020-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.